Skip to main content
. 2021 Dec 16;219(2):e20211381. doi: 10.1084/jem.20211381

Table 2. Comparison of MIS-C patients and adults with severe COVID-19.

MIS-C (n = 14) Severe adult COVID-19 (n = 94) P valuea
Demographics
Females, n (%) 7 (50) 25 (27) 0.0736
Age, yr, median (IQR) 10 (8.25–13.5) 67 (58–74) <0.0001
Race/ethnicity
White/Caucasian, n (%) 5 (35) 90 (96) <0.0001
African/Black, n (%) 4 (28) 2 (2) <0.0001
Asian/Middle Eastern, n (%) 3 (21) 1 (1) 0.0002
Other, n (%) 2 (14) 1 (1) 0.005
BMI, median (IQR) 17.8 (16.1–20.3) 28.1 (25.8–31.6) <0.0001
Co-morbidities
Cardiovascular disease, n (%) 0 (-) 32 (36) 0.0093
Arterial hypertension, n (%) 0 (-) 34 (38) 0.0066
Diabetes mellitus, n (%) 0 (-) 28 (31) 0.0177
Chronic kidney disease, n (%) 0 (-) 13 (14) 0.1379
Chronic lung disease, n (%) 0 (-) 13 (14) 0.1379
Laboratory markers at inclusion
Hb, median (IQR), g/dl 10.5 (9.9–11.2) 13.3 (12.3–14.3) <0.0001
WBC, median (IQR), × 109/liter 7.1 (5.7–10.7) 7 (5.4–9.3) 0.7004
Lymphocytes, median (IQR), × 109/liter 0.8 (0.6–1.1) 0.6 (0.5–0.8) 0.0766
Eosinophils, median (IQR), × 109/liter 0.1 (0–0.1) 0 (0–0) <0.0001
Platelets, median (IQR), × 109/liter 194.5 (172.3–229.8) 218 (155.5–291.5) 0.4366
Creatinine, median (IQR), mg/dl 0.6 (0.5–0.7) 0.9 (0.8–1.1) <0.0001
Urea, median (IQR), mg/dl 27 (17.7–37.8) 28 (22–36) 0.5339
AST, median (IQR), U/liter 33 (24–44) 54 (38–76) 0.0021
ALT, median (IQR), U/liter 38 (20–42) 44 (30–63.5) 0.1155
GGT, median (IQR), U/liter 47 (36–59) 54.5 (28.8–101.5) 0.2207
Ferritin, median (IQR), µg/liter 507 (285–736) 1,704 (1,169–2,744.5) <0.0001
Fibrinogen, median (IQR), mg/dl 523 (425–663.5) 634 (571–728) 0.0567
D-dimer, median (IQR), ng/ml 2,555 (2,002.5–4,855) 1,100 (722.5–1,486.8) 0.0006
CRP, median (IQR), mg/liter 286.4 (187.275–376.125) 130.9 (86–190.7) <0.0001

Bold and italic text indicates that P values are <0.05 and are considered significant. BMI, body mass index; Hb, hemoglobin.

a

Chi-square test (two-sided) for categorical variables, Mann–Whitney U for continuous variables, tested between adult COVID-19 and MIS-C.